Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Neurocrine Biosciences stock

Learn how to easily invest in Neurocrine Biosciences stock.

Neurocrine Biosciences is a drug manufacturers-specialty & generic business based in the US. Neurocrine Biosciences shares (NBIX) are listed on the NASDAQ and all prices are listed in US Dollars. Neurocrine Biosciences employs 1,300 staff and has a trailing 12-month revenue of around $1.6 billion.

How to buy Neurocrine Biosciences stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – NBIX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading

tastytrade


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Neurocrine Biosciences stock price (NASDAQ: NBIX)

Use our graph to track the performance of NBIX stocks over time.

Neurocrine Biosciences shares at a glance

Information last updated 2023-05-27.
Latest market close$91.22
52-week range$88.38 - $129.29
50-day moving average $98.99
200-day moving average $107.48
Wall St. target price$124.67
PE ratio 144.7937
Dividend yield $0 (0%)
Earnings per share (TTM) $0.63

Buy Neurocrine Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$0
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
tastytrade
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
$0
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Earn a 5.4% yield with government-backed Treasury bills.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
$0
$0
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Neurocrine Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Neurocrine Biosciences price performance over time

Historical closes compared with the close of $91.22 from 2023-05-26

1 week (2023-05-24) -1.50%
1 month (2023-05-01) -12.31%
3 months (2023-03-03) -9.84%
6 months (2022-12-01) -27.78%
1 year (2022-05-27) -2.02%
2 years (2021-05-28) -5.20%
3 years (2020-05-29) 124.76
5 years (2018-05-31) 96.26

Is Neurocrine Biosciences stock undervalued or overvalued?

Valuing Neurocrine Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neurocrine Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Neurocrine Biosciences financials

Revenue TTM $1.6 billion
Operating margin TTM 17.24%
Gross profit TTM $1 billion
Return on assets TTM 7.65%
Return on equity TTM 4.16%
Profit margin 4%
Book value $17.28
Market capitalisation $8.9 billion

TTM: trailing 12 months

Neurocrine Biosciences share dividends

We're not expecting Neurocrine Biosciences to pay a dividend over the next 12 months.

Neurocrine Biosciences share price volatility

Over the last 12 months, Neurocrine Biosciences's shares have ranged in value from as little as $88.38 up to $129.29. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neurocrine Biosciences's is 0.4877. This would suggest that Neurocrine Biosciences's shares are less volatile than average (for this exchange).

Neurocrine Biosciences overview

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its products include INGREZZA and DYSVAL, for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, used as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women, as well as ALKINDI SPRINKLE, for the treatment of pediatric adrenal insufficiency. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-1117568 for the treatment of schizophrenia.

Frequently asked questions

What percentage of Neurocrine Biosciences is owned by insiders or institutions?
Currently 1.06% of Neurocrine Biosciences shares are held by insiders and 95.257% by institutions.
How many people work for Neurocrine Biosciences?
Latest data suggests 1,300 work at Neurocrine Biosciences.
When does the fiscal year end for Neurocrine Biosciences?
Neurocrine Biosciences's fiscal year ends in December.
Where is Neurocrine Biosciences based?
Neurocrine Biosciences's address is: 12780 El Camino Real, San Diego, CA, United States, 92130
What is Neurocrine Biosciences's ISIN number?
Neurocrine Biosciences's international securities identification number is: US64125C1099
What is Neurocrine Biosciences's CUSIP number?
Neurocrine Biosciences's Committee on Uniform Securities Identification Procedures number is: 64125C109

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site